SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 64 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,003,167 | +35.9% | 150,100 | +33.4% | 0.03% | +11.5% |
| Q1 2021 | $2,945,250 | +4.1% | 112,500 | 0.0% | 0.03% | +18.2% |
| Q4 2020 | $2,830,500 | -40.9% | 112,500 | -35.4% | 0.02% | -40.5% |
| Q3 2019 | $4,788,000 | +2.7% | 174,223 | +23.7% | 0.04% | +8.8% |
| Q2 2019 | $4,662,000 | +179.3% | 140,893 | +195.7% | 0.03% | +142.9% |
| Q1 2019 | $1,669,000 | +5.8% | 47,641 | +52.0% | 0.01% | +40.0% |
| Q3 2018 | $1,578,000 | +447.9% | 31,340 | +552.2% | 0.01% | +400.0% |
| Q2 2018 | $288,000 | -25.2% | 4,805 | -50.2% | 0.00% | 0.0% |
| Q4 2017 | $385,000 | -84.5% | 9,652 | -83.2% | 0.00% | -87.5% |
| Q2 2017 | $2,479,000 | +12.7% | 57,500 | -18.2% | 0.02% | 0.0% |
| Q1 2017 | $2,200,000 | +73233.3% | 70,271 | +43277.2% | 0.02% | – |
| Q2 2015 | $3,000 | -99.4% | 162 | -99.6% | 0.00% | -100.0% |
| Q1 2015 | $544,000 | -87.7% | 44,990 | -91.2% | 0.00% | -90.0% |
| Q3 2014 | $4,419,000 | +61.1% | 508,536 | +103.0% | 0.03% | +30.4% |
| Q2 2014 | $2,743,000 | +2439.8% | 250,472 | +1603.9% | 0.02% | +2200.0% |
| Q3 2013 | $108,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |